Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Acute Myeloid Leukemia

Acute Myeloid Leukemia Newsletter

Current Knowledge of the Integrated Stress Response in the Development and Management of Acute Myeloid Leukemia: A Novel Target with Encouraging Progress 16 Dec 2025 20:19 GMT
… of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent … of myelodysplastic syndromes and acute myeloid leukemia: past discoveries and future … induce potent tumoricidal activity against acute myeloid leukemia (AML). Blood. 2019 …
AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers 15 Dec 2025 17:39 GMT
… DRUG CANDIDATE FOR TREATING REFRACTORY ACUTE MYELOID LEUKEMIA (AML) AND POTENTIALLY OTHER … for the treatment of refractory acute myeloid leukemia’ and is freely accessible … potential for treating high-risk acute myeloid leukemia. The data indicate that …
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC 19 Dec 2025 22:05 GMT
… patients with relapsed or refractory acute myeloid leukemia (AML) and is being developed …
<![CDATA[Oral Hypomethylating Agents: Compliance, Real-World Data, and Expanding Use ]]> 19 Dec 2025 18:59 GMT
… for high-risk MDS and acute myeloid leukemia (AML). She describes that oral …
Tolmar Announces Expanded Indication for Rubraca® (rucaparib) First and Only PARP Inhibitor to Outperform Docetaxel in a Head-to-Head Phase 3 Trial 19 Dec 2025 15:09 GMT
… INFORMATION Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) occur in patients treated …
Thrombopoietin Boosts Aggressive EVI1+ AML Stem Genes 19 Dec 2025 14:47 GMT
… on the molecular mechanisms underlying acute myeloid leukemia (AML), highlighting particularly pernicious forms … of Research: Molecular mechanisms underlying acute myeloid leukemia driven by EVI1 overexpression and …
Serum Pyroptosis-Related Cytokines as Biomarkers for Diagnostic Assessment and Risk Stratification of Ocular Graft-versus-Host Disease: A Case-Control Study 19 Dec 2025 14:01 GMT
… various underlying hematologic malignancies, with acute myeloid leukemia (AML) being the most common … hematopoietic stem cell transplantation; AML, acute myeloid leukemia; ANOVA, analysis of variance; AUC …
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager 19 Dec 2025 13:00 GMT
… , INB-100, is focused on acute myeloid leukemia, evaluating haplo-matched allogeneic γδ T …
Global MRD Testing Market Expands Rapidly as Precision Oncology Drives Early Cancer Detection 19 Dec 2025 12:33 GMT
… covers acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL …
Fundraiser for Clare mum diagnosed with blood cancer raises over €70,000 in 24 hours 19 Dec 2025 06:58 GMT
… Sarah Glenny was diagnosed with Acute Myeloid Leukemia (AML) on December 12, news …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS